Please assess the completion status of the following clinical trial:

Trial Title: Intestinal Permeability in Preterm Infants

Study Design Characteristics:
- Allocation: None
- Intervention Model: SINGLE_GROUP
- Observational Model: None
- Primary Purpose: SCREENING
- Time Perspective: None
- Masking: NONE
- Phase: PHASE1
- Number of Arms: 1.0

Eligibility Criteria:
Inclusion Criteria:~* \<5 days~* Gestational age 24-32 weeks~Exclusion criteria:~* Nonviable or planned withdrawal of care~* Significant GI dysfunction (e.g. heme-positive stools, abdominal distension (girth \>2 cm baseline), or bilious emesis/aspirates.~* Triplet or higher order multiple~* Severe asphyxia~* Lethal chromosome abnormalities~* Cyanotic congenital heart disease~* Intestinal atresia or perforation~* Abdominal wall defects~* Known galactosemia or other galactose intolerance

- Gender: ALL
- Minimum Age: None
- Maximum Age: 4 Days
- Healthy Volunteers: f

Study Arms:
- Lactulose - rhamnose solution (Type: OTHER): Preterm Infants age 24-32 weeks gestation

Based on this trial design, predict the completion outcome and termination type (if applicable).